Skip to main navigation
Skip to search
Skip to main content
Ben-Gurion University Research Portal Home
Help & FAQ
Home
Profiles
Research output
Research units
Prizes
Press/Media
Student theses
Activities
Research Labs / Equipment
Datasets
Projects
Search by expertise, name or affiliation
Should metformin be included in fertility treatment of PCOS patients?
Jigal Haas, Yaakov Bentov
Research output
:
Contribution to journal
›
Article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Should metformin be included in fertility treatment of PCOS patients?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Infertility
100%
Metformin
100%
Fertility Treatment
100%
PCOS Patient
100%
Embryo Development
40%
ATP Production
40%
Therapeutic Effect
20%
Electron Transport
20%
Safe Use
20%
During Pregnancy
20%
Prescription Drugs
20%
Oocyte Maturation
20%
Type 2 Diabetic Patients
20%
Gestational Diabetes
20%
Pregnancy Duration
20%
Birth Defects
20%
Pregnancy Loss
20%
Metabolic Characteristics
20%
Early Embryonic Development
20%
Mitochondrial Electron Transport Chain
20%
Impaired Glucose Tolerance
20%
Preconception Period
20%
Medicine and Dentistry
Assisted Reproductive Technology
100%
Glycon
100%
Adenosine Triphosphate
60%
Embryo Development
60%
Drug Therapy
20%
Electron Transport
20%
Congenital Malformation
20%
Conception
20%
Child
20%
Gestational Diabetes
20%
Patient with Type 2 Diabetes
20%
Impaired Glucose Tolerance
20%
Oocyte Maturation
20%
Respiratory Chain
20%
Therapy Effect
20%
Nursing and Health Professions
Infertility Therapy
100%
Metformin
100%
Adenosine Triphosphate
60%
Drug Therapy
20%
Child
20%
Patient with Type 2 Diabetes
20%
Congenital Malformation
20%
Pregnancy Diabetes Mellitus
20%
Therapy Effect
20%
Impaired Glucose Tolerance
20%
Pharmacology, Toxicology and Pharmaceutical Science
Metformin
100%
Adenosine Triphosphate
60%
Therapeutic Effect
20%
Non Insulin Dependent Diabetes Mellitus
20%
Pregnancy Diabetes Mellitus
20%
Congenital Malformation
20%
Impaired Glucose Tolerance
20%